 | This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. Please help improve this article by introducing more precise citations. (June 2019) (Learn how and when to remove this message) |
 | This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Ortho-McNeil-Janssen" – news · newspapers · books · scholar · JSTOR (October 2024) |
Ortho-McNeil-Janssen Pharmaceuticals, Inc is a healthcare company of Johnson & Johnson composed of two divisions:
- Ortho-McNeil, based in Raritan, NJ (United States); the division is focused on primary care.
- Janssen, based in Beerse (Belgium); formerly Janssen Pharmaceutica; the division is focused on mental health.
After some suits against Ortho-McNeil, Johnson & Johnson came to an agreement about the future of this subsidiary branch, now known as Janssen Pharmaceuticals.
See also
References
- "Johnson & Johnson Creates Primary Care Unit From Ortho-McNeil And Janssen". Pink Sheet. 2005-12-19. Retrieved 2024-10-13.
- "Case Study: Janssen Pharmaceutica ' | ipl.org". www.ipl.org. Retrieved 2024-10-13.
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Misplaced Pages by expanding it. |